|
According to the facility contact there was a hair reported inside the syringe's fluid pathway.Per the facility the hair was noticed prior to use on a patient and therefore no patient injury or medical intervention was required related to the reported incident.The sample was requested for evaluation.To date, no information has been received to indicate that a user or a patient experienced a death, serious injury, medical intervention, follow-up care, or other adverse health impact associated with the reported problem/issue.In an abundance of caution, and in response to an fda 483 issued for cfn 1417592 on 22-jan-2024, this medwatch is being filed for the reported problem/issue.If additional relevant information becomes available a supplemental medwatch will be filed.
|